Validation of flavonoids as potential dipeptidyl peptidase III inhibitors: Experimental and computational approach

Fifteen flavonoids were studied for their inhibitory activity against human dipeptidyl peptidase III (hDPP III) combining an in vitro assay with an in silico molecular modeling study. All analyzed flavonoids showed inhibitory effects against hDPP III with the IC50 values ranging from 22.0 to 437.2 μm. Our 3D QSAR studies indicate that the presence of hydrophilic regions at a flavonoid molecule increases its inhibitory activity, while the higher percentage of hydrophobic surfaces has negative impact on enzyme inhibition. Furthermore, molecular dynamics (MD) simulations of the complex of hDPP III with one of the most potent inhibitors, luteolin, were performed, and binding mode analysis revealed that the 3′ and 4′ hydroxyl group on B‐ring as well as 5 and 7 hydroxyl group on A‐ring helps luteolin to interact with the Asn391, Asn406, Tyr417, His450, Glu451, Val447, Glu512, Asn545, Gln566, and Arg572 residues. The MD results clearly provide valuable information explaining the importance of flavonoid hydroxyl groups in the mechanism for the binding pattern at the active site of hDPP III.

[1]  T. Pavkov-Keller,et al.  Substrate complexes of human dipeptidyl peptidase III reveal the mechanism of enzyme inhibition , 2016, Scientific Reports.

[2]  S. Nikolic,et al.  Synthesis, QSAR, and Molecular Dynamics Simulation of Amidino-substituted Benzimidazoles as Dipeptidyl Peptidase III Inhibitors. , 2015, Acta chimica Slovenica.

[3]  S. Tomić,et al.  Hunting the human DPP III active conformation: combined thermodynamic and QM/MM calculations. , 2014, Dalton transactions.

[4]  Bridgid E Hast,et al.  Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination. , 2013, Cancer research.

[5]  S. Garcia-Vallvé,et al.  Inhibition of Angiotensin-Converting Enzyme Activity by Flavonoids: Structure-Activity Relationship Studies , 2012, PloS one.

[6]  Miguel González,et al.  The Large Scale Conformational Change of the Human DPP III-Substrate Prefers the "Closed" Form , 2012, J. Chem. Inf. Model..

[7]  G. A. Bezerra,et al.  Entropy-driven binding of opioid peptides induces a large domain motion in human dipeptidyl peptidase III , 2012, Proceedings of the National Academy of Sciences.

[8]  S. Tomić,et al.  Human Dipeptidyl Peptidase III : the Role of Asn406 in Ligand Binding and Hydrolysis , 2011 .

[9]  R. Kharb,et al.  Pharmacological significance of triazole scaffold , 2011, Journal of enzyme inhibition and medicinal chemistry.

[10]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[11]  M. Abramić,et al.  Human dipeptidyl peptidase III acts as a post-proline-cleaving enzyme on endomorphins , 2009, Biological chemistry.

[12]  D. Agić,et al.  Absolutely conserved tryptophan in M49 family of peptidases contributes to catalysis and binding of competitive inhibitors. , 2009, Bioorganic chemistry.

[13]  M. Šikić,et al.  Metals in proteins: correlation between the metal-ion type, coordination number and the amino-acid residues involved in the coordination. , 2008, Acta crystallographica. Section D, Biological crystallography.

[14]  M. Hranjec,et al.  Novel amidino-substituted benzimidazoles: synthesis of compounds and inhibition of dipeptidyl peptidase III. , 2007, Bioorganic chemistry.

[15]  P. Schultz,et al.  A genomic screen for activators of the antioxidant response element , 2007, Proceedings of the National Academy of Sciences.

[16]  Rolf Gebhardt,et al.  Inhibition of Matrix Metalloproteinase-2 and -9 Activities by Selected Flavonoids , 2004, Planta medica.

[17]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[18]  Liliana Jiménez,et al.  Polyphenols: food sources and bioavailability. , 2004, The American journal of clinical nutrition.

[19]  M. Osmak,et al.  Tumor cytosol dipeptidyl peptidase III activity is increased with histological aggressiveness of ovarian primary carcinomas. , 2003, Gynecologic oncology.

[20]  P. Auguste,et al.  Characterization of a functionally expressed dipeptidyl aminopeptidase III from Drosophila melanogaster. , 2003, European journal of biochemistry.

[21]  R. Arai,et al.  Inhibition of recombinant dipeptidyl peptidase III by synthetic hemorphin-like peptides , 2003, Peptides.

[22]  K. Fukasawa,et al.  Purification, partial sequencing and characterization of an insect membrane dipeptidyl aminopeptidase that degrades the insect neuropeptide proctolin. , 2001, European journal of biochemistry.

[23]  P. Carrupt,et al.  Molecular fields in quantitative structure–permeation relationships: the VolSurf approach , 2000 .

[24]  Teruhide Yamaguchi,et al.  Characterization of tynorphin, a potent endogenous inhibitor of dipeptidyl peptidaseIII , 2000, Peptides.

[25]  Lee G. Pedersen,et al.  Ionic charging free energies: Spherical versus periodic boundary conditions , 1998 .

[26]  J. Parellada,et al.  Inhibition of zinc metallopeptidases by flavonoids and related phenolic compounds: structure-activity relationships. , 1998, Journal of enzyme inhibition.

[27]  Y. Yamamoto,et al.  Inhibitory action of spinorphin, an endogenous regulator of enkephalin-degrading enzymes, on carrageenan-induced polymorphonuclear neutrophil accumulation in mouse air-pouches. , 1998, Life sciences.

[28]  M. Osmak,et al.  Dipeptidyl peptidase III in malignant and non-malignant gynaecological tissue. , 1998, European journal of cancer.

[29]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[30]  T. Hazato,et al.  Isolation and identification of an endogenous inhibitor of enkephalin-degrading enzymes from bovine spinal cord. , 1993, Biochemical and biophysical research communications.

[31]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[32]  A. Taylor.  Aminopeptidases: structure and function , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  T. H. Jones,et al.  The purification, specificity, and role of dipeptidyl peptidase III in , 1992 .

[34]  Y. Watanabe,et al.  Presence of a dipeptidyl aminopeptidase III in Saccharomyces cerevisiae. , 1990, Chemical & pharmaceutical bulletin.

[35]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[36]  S. Snyder,et al.  Dipeptidyl-aminopeptidase III of rat brain. Selective affinity for enkephalin and angiotensin. , 1982, The Journal of biological chemistry.

[37]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[38]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[39]  S. Tomić,et al.  Importance of the three basic residues in the vicinity of the zinc-binding motifs for the activity of the yeast dipeptidyl peptidase III. , 2014, Journal of biochemistry.

[40]  D. Agić,et al.  Reactive cysteine in the active-site motif of Bacteroides thetaiotaomicron dipeptidyl peptidase III is a regulatory residue for enzyme activity , 2012, Biological chemistry.

[41]  Rebecca C Wade,et al.  Mechanism of auxin interaction with Auxin Binding Protein (ABP1): a molecular dynamics simulation study. , 2008, Biophysical journal.

[42]  L. Vitale,et al.  Dipeptidyl peptidase III from human erythrocytes. , 1988, Biological chemistry Hoppe-Seyler.